Click on a CareFusion Infusion product below for a list of available white papers on that topic:
Alaris® SE single and dual channel pumps
Alaris® System
Alaris® System - ROI
Gemini infusion system
MaxGuard® IV sets and accessories
MedSystem III® infusion pump
SmartSite® needle-free valve
Texium® IV accessories
Click on a CareFusion Infusion product below for a list of available directions for use (DFU) on that topic:
Alaris® SE single and dual channel pumps
Alaris® System (includes DFU for each module)
Alaris® System quick reference guides / hang tags v8
MaxGuard® IV sets and accessoriesMedSystem III® infusion SystemSmartSite® IV sets and accessories
Click on the links below for a list of frequently asked questions on that topic:
Administration
Alaris® System
Alaris® Pump module
Alaris® Syringe module
Alaris® SE single and dual channel pumps
Gemini infusion system
MaxGuard® IV sets and accessories
SmartSite® IV sets and accessories
HIPAA Documents
Manufacturer Disclosure Statement for Medical Device Security (MDS2)
The intent of the MDS2 is to supply healthcare providers with important information that can assist them in assessing the vulnerability and risks associated with electronic Protected Health Information (ePHI) transmitted or maintained by a product. Security risk assessment is a broad, organization-wide effort, therefore this document focuses on only those elements of the risk assessment process associated with products and systems that maintain or transmit ePHI. The MDS2 was created by the HIMSS Medical Device Security Workgroup and is in compliance with the HIPAA Security Rule.
For additional information please contact Customer Advocacy at 888.812.3266 or customerfeedback@carefusion.com